More From Employee Benefit News
Forging stronger broker-TPA partnerships
Collaboration between employers, brokers and third-party administrators will be essential to developing customized, cost-effective and employee-friendly solutions.
3 ways women are still struggling in the workplace, and what benefits could help
The needs of women continue to outpace organizations' inclusion efforts, which will be costly if unaddressed.
Employers face a new GLP-1 question: Are the drugs worth it?
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
What Trump’s ‘Great Healthcare Plan’ means for drug costs and price transparency
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
What to know about GLP-1 demand, expense and alternatives
Multiple experts weigh in on the challenges and considerations benefit leaders need to keep in mind as they make decisions about medication coverage.
